Silence Therapeutics (SLN) Net Margin (2024 - 2026)
Silence Therapeutics (SLN) posted Net Margin of 3544.31% for Q1 2026, up 89.76% sequentially from 34617.65% in Q4 2025, and up 1654724.0% YoY from N/an in Q1 2025.
Silence Therapeutics (SLN) Net Margin (2024 - 2026) Analysis & Trends
Silence Therapeutics has reported Net Margin for 3 years, with the latest figure at 3544.31% in Q1 2026.
- Quarterly Net Margin rose 1654724.0% year-over-year to 3544.31% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 8943.86% (down 872917.0% YoY) and the FY2025 annual result came in at 15851.88%, down 1578255.0% from the prior year.
- Net Margin rose to 3544.31% in Q1 2026 per SLN's latest filing, from 34617.65% in the prior quarter.
- Over five years, Net Margin peaked at 95.88% in Q4 2024 and troughed at 34617.65% in Q4 2025.
- A 3-year average of 9823.03% and a median of 3544.31% in 2026 frame the typical range for Net Margin.
- The sharpest annual moves came in 2025 and 2026: Net Margin sank 3471353 bps in 2025, then soared 1654724 bps in 2026.
- Over 3 years, Net Margin stood at 95.88% in 2024, then tumbled by 36204 bps to 34617.65% in 2025, then soared by 90 bps to 3544.31% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 3544.31%, 34617.65%, and 13181.13% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 30.33% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.90% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 30.98% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 12.74% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -3.12% |
| 10 | Silence Therapeutics | 648.22 Mn | 576.12 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,544.31% |
| Dec 31, 2025 | -34,617.65% |
| Sep 30, 2025 | -13,181.13% |
| Jun 30, 2025 | -12,211.61% |
| Mar 31, 2025 | -20,091.55% |
| Dec 31, 2024 | 95.88% |
| Sep 30, 2024 | -2,372.76% |
| Jun 30, 2024 | -2,469.38% |
| Mar 31, 2024 | -14.73% |